Richard Verrelli
About Richard Verrelli
Richard Verrelli is a Senior Clinical Trial Manager at Bristol Myers Squibb in Melbourne, Victoria, Australia, with extensive experience in clinical research and management roles.
Company
Richard Verrelli currently works as a Senior Clinical Trial Manager at Bristol Myers Squibb in Melbourne, Victoria, Australia. He joined the company in May 2020 and transitioned to his current role in July 2021.
Title
Richard Verrelli holds the position of Senior Clinical Trial Manager. His role involves overseeing clinical trials, ensuring that they adhere to regulatory standards, and managing various aspects of the clinical trial process.
Education and Expertise
Richard Verrelli has a comprehensive educational background, including a Bachelor of Biomedical Science from Monash University and a Masters of Applied Commerce from the University of Melbourne. He also completed the Chameleon Leadership Program at Melbourne Business School in 2018, focusing on Executive Leadership. His experience spans across clinical research phases and therapeutic areas, making him highly knowledgeable in his field.
Professional Background
Richard Verrelli's career includes extensive roles in clinical research and management. He served as Clinical Research Associate at PPD from 2008 to 2011 and climbed the ranks to become Principal Clinical Research Associate by 2013. He joined The Royal Melbourne Hospital & NorthWestern Mental Health in 2015, where he was Clinical Research Manager and later Head of Operations, Clinical Research and Clinical Trials Centre. In his various roles, he oversaw operational management, business development, stakeholder engagement, and feasibility reviews for studies.
Innovative Leadership in Clinical Trials
Richard Verrelli is recognized as an innovative leader in clinical trials. Known for being highly innovative and a strong advocate for industry collaboration, he focuses on process improvement and evidence-based decision making. He aims to positively impact the clinical research industry in Australia to ensure the market availability of safe and effective drugs and devices.